Jacobsen Capital Management Lowers Stake in UnitedHealth Group Incorporated $UNH

Jacobsen Capital Management lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 52.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 682 shares of the healthcare conglomerate’s stock after selling 758 shares during the quarter. Jacobsen Capital Management’s holdings in UnitedHealth Group were worth $213,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Studio Investment Management LLC grew its position in shares of UnitedHealth Group by 2.3% during the second quarter. Studio Investment Management LLC now owns 7,427 shares of the healthcare conglomerate’s stock valued at $2,317,000 after purchasing an additional 165 shares in the last quarter. Private Capital Advisors Inc. grew its holdings in UnitedHealth Group by 1.6% during the 2nd quarter. Private Capital Advisors Inc. now owns 37,685 shares of the healthcare conglomerate’s stock valued at $11,757,000 after buying an additional 608 shares in the last quarter. D.A. Davidson & CO. raised its holdings in shares of UnitedHealth Group by 33.7% during the 2nd quarter. D.A. Davidson & CO. now owns 56,801 shares of the healthcare conglomerate’s stock worth $17,720,000 after acquiring an additional 14,315 shares in the last quarter. Blume Capital Management Inc. increased its position in UnitedHealth Group by 954.3% in the second quarter. Blume Capital Management Inc. now owns 3,068 shares of the healthcare conglomerate’s stock worth $957,000 after purchasing an additional 2,777 shares during the last quarter. Finally, Gables Capital Management Inc. increased its stake in UnitedHealth Group by 219.8% during the second quarter. Gables Capital Management Inc. now owns 4,065 shares of the healthcare conglomerate’s stock worth $1,268,000 after acquiring an additional 2,794 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3%

NYSE:UNH opened at $365.47 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The firm has a 50 day moving average of $333.70 and a 200 day moving average of $341.28. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $331.00 billion, a price-to-earnings ratio of 15.83, a PEG ratio of 2.36 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s payout ratio is currently 38.30%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on UNH shares. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Sanford C. Bernstein increased their target price on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. Mizuho upped their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Weiss Ratings reissued a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday, October 8th. Finally, Barclays boosted their price target on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.